Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Extended-spectrum antiprotozoal bumped kinase inhibitors: A review.

Van Voorhis WC, Doggett JS, Parsons M, Hulverson MA, Choi R, Arnold S, Riggs MW, Hemphill A, Howe DK, Mealey RH, Lau AO, Merritt EA, Maly DJ, Fan E, Ojo KK.

Exp Parasitol. 2017 Jan 5. pii: S0014-4894(17)30005-X. doi: 10.1016/j.exppara.2017.01.001. [Epub ahead of print]

PMID:
28065755
2.

Antibody escape kinetics of equine infectious anemia virus infection of horses.

Schwartz EJ, Nanda S, Mealey RH.

J Virol. 2015 Jul;89(13):6945-51. doi: 10.1128/JVI.00137-15.

3.

Theileria equi isolates vary in susceptibility to imidocarb dipropionate but demonstrate uniform in vitro susceptibility to a bumped kinase inhibitor.

Hines SA, Ramsay JD, Kappmeyer LS, Lau AO, Ojo KK, Van Voorhis WC, Knowles DP, Mealey RH.

Parasit Vectors. 2015 Jan 20;8:33. doi: 10.1186/s13071-014-0611-6.

4.

Effects of dexamethasone and Mycoplasma bovis on bovine neutrophil function in vitro.

Alabdullah HA, Fox LK, Gay JM, Barrington GM, Mealey RH.

Vet Immunol Immunopathol. 2015 Mar 15;164(1-2):67-73. doi: 10.1016/j.vetimm.2014.12.010.

PMID:
25593042
5.

Experimental transmission of equine hepacivirus in horses as a model for hepatitis C virus.

Ramsay JD, Evanoff R, Wilkinson TE Jr, Divers TJ, Knowles DP, Mealey RH.

Hepatology. 2015 May;61(5):1533-46. doi: 10.1002/hep.27689.

PMID:
25580897
6.

In contrast to other species, α-Galactosylceramide (α-GalCer) is not an immunostimulatory NKT cell agonist in horses.

Dossa RG, Alperin DC, Garzon D, Mealey RH, Brown WC, Jervis PJ, Besra GS, Cox LR, Hines SA.

Dev Comp Immunol. 2015 Mar;49(1):49-58. doi: 10.1016/j.dci.2014.11.005.

PMID:
25445911
7.

New perspectives in infectious diseases.

Mealey RH.

Vet Clin North Am Equine Pract. 2014 Dec;30(3):xv-xvi. doi: 10.1016/j.cveq.2014.10.001. No abstract available.

PMID:
25441118
8.

Equine infectious anemia in 2014: live with it or eradicate it?

Issel CJ, Cook RF, Mealey RH, Horohov DW.

Vet Clin North Am Equine Pract. 2014 Dec;30(3):561-77. doi: 10.1016/j.cveq.2014.08.002. Review.

PMID:
25441114
9.

Equine piroplasmosis.

Wise LN, Pelzel-McCluskey AM, Mealey RH, Knowles DP.

Vet Clin North Am Equine Pract. 2014 Dec;30(3):677-93. doi: 10.1016/j.cveq.2014.08.008. Review.

PMID:
25300637
10.

Lymphocytes and macrophages are infected by Theileria equi, but T cells and B cells are not required to establish infection in vivo.

Ramsay JD, Ueti MW, Johnson WC, Scoles GA, Knowles DP, Mealey RH.

PLoS One. 2013 Oct 7;8(10):e76996. doi: 10.1371/journal.pone.0076996.

11.

Serum antibodies from a subset of horses positive for Babesia caballi by competitive enzyme-linked immunosorbent assay demonstrate a protein recognition pattern that is not consistent with infection.

Awinda PO, Mealey RH, Williams LB, Conrad PA, Packham AE, Reif KE, Grause JF, Pelzel-McCluskey AM, Chung C, Bastos RG, Kappmeyer LS, Howe DK, Ness SL, Knowles DP, Ueti MW.

Clin Vaccine Immunol. 2013 Nov;20(11):1752-7. doi: 10.1128/CVI.00479-13.

12.

Review of equine piroplasmosis.

Wise LN, Kappmeyer LS, Mealey RH, Knowles DP.

J Vet Intern Med. 2013 Nov-Dec;27(6):1334-46. doi: 10.1111/jvim.12168. Review.

13.

Comparative genomic analysis and phylogenetic position of Theileria equi.

Kappmeyer LS, Thiagarajan M, Herndon DR, Ramsay JD, Caler E, Djikeng A, Gillespie JJ, Lau AO, Roalson EH, Silva JC, Silva MG, Suarez CE, Ueti MW, Nene VM, Mealey RH, Knowles DP, Brayton KA.

BMC Genomics. 2012 Nov 9;13:603. doi: 10.1186/1471-2164-13-603.

14.

Re-emergence of the apicomplexan Theileria equi in the United States: elimination of persistent infection and transmission risk.

Ueti MW, Mealey RH, Kappmeyer LS, White SN, Kumpula-McWhirter N, Pelzel AM, Grause JF, Bunn TO, Schwartz A, Traub-Dargatz JL, Hendrickson A, Espy B, Guthrie AJ, Fowler WK, Knowles DP.

PLoS One. 2012;7(9):e44713. doi: 10.1371/journal.pone.0044713.

15.

Protective effects of passively transferred merozoite-specific antibodies against Theileria equi in horses with severe combined immunodeficiency.

Mealey RH, Kappmeyer LS, Ueti MW, Wagner B, Knowles DP.

Clin Vaccine Immunol. 2012 Jan;19(1):100-4. doi: 10.1128/CVI.05301-11.

16.

Decreased infectivity of a neutralization-resistant equine infectious anemia virus variant can be overcome by efficient cell-to-cell spread.

Wu W, Blythe DC, Loyd H, Mealey RH, Tallmadge RL, Dorman KS, Carpenter S.

J Virol. 2011 Oct;85(19):10421-4. doi: 10.1128/JVI.05349-11.

17.
18.

Early development of cytotoxic T lymphocytes in neonatal foals following oral inoculation with Rhodococcus equi.

Harris SP, Hines MT, Mealey RH, Alperin DC, Hines SA.

Vet Immunol Immunopathol. 2011 Jun 15;141(3-4):312-6. doi: 10.1016/j.vetimm.2011.03.015.

19.

Evaluation of an arthroscopic approach for transection of the equine collateral sesamoidean ligament.

Sampson SN, Schneider RK, Gavin PR, Baszler TV, Mealey RH, Zubrod CJ, Marsh CA.

Vet Surg. 2010 Dec;39(8):1011-20. doi: 10.1111/j.1532-950X.2010.00745.x.

PMID:
21070264
20.

Development of a DNA microarray for detection of expressed equine classical MHC class I sequences in a defined population.

Ramsay JD, Leib SR, Orfe L, Call DR, Tallmadge RL, Fraser DG, Mealey RH.

Immunogenetics. 2010 Sep;62(9):633-9. doi: 10.1007/s00251-010-0463-y.

Items per page

Supplemental Content

Loading ...
Support Center